SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 26.89 |
Enterprise Value ($M) | 21.98 |
Book Value ($M) | -16.58 |
Book Value / Share | -0.42 |
Price / Book | -1.62 |
NCAV ($M) | -17.43 |
NCAV / Share | -0.44 |
Price / NCAV | -1.54 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -1.85 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.93 |
Current Ratio | 0.93 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 9.47 |
Assets | 10.32 |
Liabilities | 26.90 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Gkcc, Llc | 11.79 | ||
13D | Armen Garo H | 9.68 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
3,592 | 55,405 | 6.48 | |
7,385 | 32,903 | 22.44 | |
3,649 | 23,865 | 15.29 | |
2,154 | 21,641 | 9.95 | |
(click for more detail) |
Similar Companies | |
---|---|
IMNN – Imunon, Inc. | IMTX – Immatics N.V. |
INDP – Indaptus Therapeutics, Inc. | INM – InMed Pharmaceuticals Inc. |
INMB – INmune Bio, Inc. |
Financial data and stock pages provided by
Fintel.io